3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Myelodysplastic Syndromes
48
Leukemia, Myeloid, Acute
43
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Leukemia
19
Hodgkin Disease
18
Lymphoma, Non-Hodgkin
17
Multiple Myeloma
14
Leukemia, Lymphocytic, Chronic, B-Cell
13
Primary Myelofibrosis
12
Leukemia, Myelomonocytic, Chronic
11
Myeloproliferative Disorders
10
Lymphoma
10
Graft vs Host Disease
8
Leukemia, Biphenotypic, Acute
7
Leukemia, Myelomonocytic, Juvenile
6
Polycythemia Vera
4
Lymphoma, Follicular
4
Leukemia, Myeloid, Accelerated Phase
4
Hemoglobinuria, Paroxysmal
4
Anemia, Aplastic
4
Thrombocythemia, Essential
3
Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Hematologic Neoplasms
3
Hematologic Diseases
3
Blast Crisis
3
Anemia, Refractory, with Excess of Blasts
3
Interventions
ruxolitinib
1
Stem Cell Transplantation
1
SCIO-469
1
Hydroxyurea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Marrow Neoplasms
×
Stem Cell Transplantation
×
Myeloid
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled